{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:40:18Z","timestamp":1794462018576,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97831-5","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:38:46Z","timestamp":1744371526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Mechanism of dracorhodin in accelerating diabetic foot ulcer healing via the Nrf2 pathway, a network pharmacology, molecular docking and experimental validation"],"prefix":"10.1038","volume":"15","author":[{"given":"Guangjun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junde","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"10397","key":"97831_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and National burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet 402(10397), 203\u2013234 (2023).","journal-title":"Lancet"},{"key":"97831_CR2","unstructured":"International Diabetes Federation. The Diabetic Foot. Brussels, Belgium & Federation, I. D. https:\/\/www.idf.org\/our-activities\/care-prevention\/diabetic-foot.html (Accessed 1 Aug 2022) (2020)."},{"key":"97831_CR3","doi-asserted-by":"publisher","first-page":"117058","DOI":"10.1016\/j.biopha.2024.117058","volume":"177","author":"JP Yadav","year":"2024","unstructured":"Yadav, J. P. et al. Phytoconstituents as modulators of NF-\u03baB signalling: investigating therapeutic potential for diabetic wound healing. Biomed. Pharmacother. 177, 117058 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"97831_CR4","doi-asserted-by":"crossref","unstructured":"Deng, P. et al. Worldwide research trends on diabetic foot ulcer (2004\u20132020): Suggestions for researchers. J. Diabetes Res. 2022, 7991031. (2022).","DOI":"10.1155\/2022\/7991031"},{"issue":"1","key":"97831_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/dom.14840","volume":"25","author":"L Chen","year":"2023","unstructured":"Chen, L., Sun, S., Gao, Y. & Ran, X. Global mortality of diabetic foot ulcer: A systematic review and meta-analysis of observational studies. Diabetes Obes. Metab. 25(1), 36\u201345 (2023).","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"97831_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2337\/dci22-0043","volume":"46","author":"K McDermott","year":"2023","unstructured":"McDermott, K., Fang, M., Boulton, A. J. M., Selvin, E. & Hicks, C. W. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care. 46(1), 209\u2013221 (2023).","journal-title":"Diabetes Care"},{"issue":"1","key":"97831_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2023.10578","volume":"330","author":"DG Armstrong","year":"2023","unstructured":"Armstrong, D. G., Tan, T. W., Boulton, A. J. M. & Bus, S. A. Diabetic foot ulcers: A review. JAMA 330(1), 62\u201375 (2023).","journal-title":"JAMA"},{"key":"97831_CR8","doi-asserted-by":"crossref","unstructured":"Yadav, J. P., Patel, D. K., Verma, A. & Pathak, P. Revolutionizing diabetic wound healing: targeted therapeutic strategies based on growth factors. Obes. Med. 47, 100535. (2024).","DOI":"10.1016\/j.obmed.2024.100535"},{"issue":"8","key":"97831_CR9","doi-asserted-by":"publisher","first-page":"e031122210617","DOI":"10.2174\/1573399819666221103141715","volume":"19","author":"V Ramachandran","year":"2023","unstructured":"Ramachandran, V., Mohanasundaram, T., Karunakaran, D., Gunasekaran, M. & Tiwari, R. Physiological and pathophysiological aspects of diabetic foot ulcer and its treatment strategies. Curr. Diabetes Rev. 19(8), e031122210617 (2023).","journal-title":"Curr. Diabetes Rev."},{"issue":"1","key":"97831_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2337\/dci22-0043","volume":"46","author":"K McDermott","year":"2023","unstructured":"McDermott, K., Fang, M., Boulton, A. J. M., Selvin, E. & Hicks, C. W. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcer. Diabetes Care. 46(1), 209\u2013221 (2023).","journal-title":"Diabetes Care"},{"issue":"1","key":"97831_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2023.10578","volume":"330","author":"DG Armstrong","year":"2023","unstructured":"Armstrong, D. G., Tan, T. W., Boulton, A. J. M. & Bus, S. A. Diabetic foot ulcer: A review. JAMA 330(1), 62\u201375 (2023).","journal-title":"JAMA"},{"issue":"1","key":"97831_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/nyas.13569","volume":"1411","author":"E Everett","year":"2018","unstructured":"Everett, E. & Mathioudakis, N. Update on management of diabetic foot ulcer. Ann. N Y Acad. Sci. 1411(1), 153\u2013165 (2018).","journal-title":"Ann. N Y Acad. Sci."},{"key":"97831_CR13","doi-asserted-by":"publisher","first-page":"112713","DOI":"10.1016\/j.intimp.2024.112713","volume":"139","author":"F Mohsin","year":"2024","unstructured":"Mohsin, F., Javaid, S., Tariq, M. & Mustafa, M. Molecular immunological mechanisms of impaired wound healing in diabetic foot ulcer (DFU), current therapeutic strategies and future directions. Int. Immunopharmacol. 139, 112713 (2024).","journal-title":"Int. Immunopharmacol."},{"issue":"15","key":"97831_CR14","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.7150\/ijbs.88461","volume":"19","author":"JY Song","year":"2023","unstructured":"Song, J. Y. et al. Deciphering the emerging role of programmed cell death in diabetic wound Healing. Int. J. Biol. Sci. 19(15), 4989\u20135003 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"97831_CR15","unstructured":"Zhang, Y. Study on the Repairing Effect and Mechanism of Ferrostatin-1 on Ulcer Wounds in High Glucose Environment Based on iron Death Pathway (Tianjin Medical University, 2021)."},{"key":"97831_CR16","doi-asserted-by":"crossref","unstructured":"Miraj, S. S. et al. Phytotherapy in diabetic foot ulcer: A promising strategy for effective wound healing. J. Am. Nutr. Assoc. 42(3), 295\u2013310 (2023).","DOI":"10.1080\/07315724.2022.2034069"},{"key":"97831_CR17","unstructured":"Yan, L. Y. Z. H. A briefanalysis ofthe external use ofancient remedies named after the efficacy of muscle growth in ancient texts. J. Guangzhou Univ. Chin. Med. 19(3), 234\u2013235 ."},{"issue":"07","key":"97831_CR18","first-page":"32","volume":"30","author":"XY Pan","year":"2022","unstructured":"Pan, X. Y. et al. Clinical study on the treatment of diabetic foot ulcer wounds with compound blood exhaust powder. Chin. J. Orthop. Traumatol. 30(07), 32\u201337 (2022).","journal-title":"Chin. J. Orthop. Traumatol."},{"issue":"2","key":"97831_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jphs.2017.12.003","volume":"136","author":"X Jiang","year":"2018","unstructured":"Jiang, X. et al. Dracorhodin perchlorate regulates fibroblast proliferation to promote rat\u2019s wound healing. J. Pharmacol. Sci. 136(2), 66\u201372 (2018).","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"97831_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40529-024-00415-1","volume":"65","author":"YH Ching","year":"2024","unstructured":"Ching, Y. H. et al. Hypoglycemic effects of dracorhodin and dragon blood crude extract from Daemonorops draco. Bot. Stud. 65(1), 8 (2024).","journal-title":"Bot. Stud."},{"key":"97831_CR21","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. Dracorhodin targeting CMPK2 attenuates inflammation: A novel approach to sepsis therapy. Clin. Transl. Med. 13(10), e1449 (2023).","DOI":"10.1002\/ctm2.1449"},{"key":"97831_CR22","doi-asserted-by":"publisher","first-page":"1038656","DOI":"10.3389\/fphar.2022.1038656","volume":"13","author":"P Deng","year":"2022","unstructured":"Deng, P. et al. Combined metabolomics and network pharmacology to elucidate the mechanisms of dracorhodin perchlorate in treating diabetic foot ulcer rats. Front. Pharmacol. 13, 1038656 (2022).","journal-title":"Front. Pharmacol."},{"key":"97831_CR23","doi-asserted-by":"publisher","first-page":"106109","DOI":"10.1016\/j.intimp.2019.106109","volume":"79","author":"X Nie","year":"2020","unstructured":"Nie, X. et al. Asiaticoside nitric oxide gel accelerates diabetic cutaneous ulcers healing by activating Wnt\/\u03b2-catenin signaling pathway. Int. Immunopharmacol. 79, 106109 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"D1","key":"97831_CR24","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"97831_CR25","doi-asserted-by":"crossref","unstructured":"Lavery, L. A. et al. WHS (Wound Healing Society) guidelines update: diabetic foot ulcer treatment guidelines. Wound Repair Regener. 32(1), 34\u201346. (2024).","DOI":"10.1111\/wrr.13133"},{"key":"97831_CR26","doi-asserted-by":"crossref","unstructured":"Kang, Y. et al. Programmed microalgae-gel promotes chronic wound healing in diabetes. Nat. Commun. 15(1), 1042. (2024).","DOI":"10.1038\/s41467-024-45101-9"},{"key":"97831_CR27","doi-asserted-by":"publisher","first-page":"117638","DOI":"10.1016\/j.jep.2023.117638","volume":"323","author":"C Xu","year":"2024","unstructured":"Xu, C. et al. Gynura divaricata (L.) DC. promotes diabetic wound healing by activating Nrf2 signaling in diabetic rats. J. Ethnopharmacol. 323, 117638 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"97831_CR28","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.7150\/ijms.100468","volume":"21","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Integrating network pharmacology, molecular docking and experimental validation to explore the pharmacological mechanisms of quercetin against diabetic wound. Int. J. Med. Sci. Vol. 21, 14 2837\u20132850 (2024).","journal-title":"Int. J. Med. Sci. Vol"},{"issue":"16","key":"97831_CR29","doi-asserted-by":"publisher","first-page":"9010","DOI":"10.3390\/ijms23169010","volume":"23","author":"L D\u00edaz-Flores","year":"2022","unstructured":"D\u00edaz-Flores, L. et al. Comparison of the behavior of perivascular cells (pericytes and CD34+\u2009stromal cell\/telocytes) in sprouting and intussusceptive angiogenesis. Int. J. Mol. Sci. 23(16), 9010 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"97831_CR30","doi-asserted-by":"crossref","unstructured":"Xing, Z. et al. IDO1 inhibitor RY103 suppresses Trp-GCN2-mediated angiogenesis and counters immunosuppression in glioblastoma. Pharmaceutics. 16(7), 870 (2024).","DOI":"10.3390\/pharmaceutics16070870"},{"issue":"3","key":"97831_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ddr.21763","volume":"82","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Paeoniflorin inhibited nod-like receptor protein-3 inflammasome and NF-\u03baB-mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR2. Drug Dev. Res.. 82(3), 404\u2013411 (2021).","journal-title":"Drug Dev. Res."},{"key":"97831_CR32","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Fibroblast growth factor in diabetic foot ulcer: progress and therapeutic prospects. Front. Endocrinol. 12(14), 744868. (2021).","DOI":"10.3389\/fendo.2021.744868"},{"key":"97831_CR33","doi-asserted-by":"crossref","unstructured":"Sch\u00f6nborn, M. et al. Circulating angiogenic factors and ischemic diabetic foot syndrome advancement\u2014A pilot study. Biomedicines 11(6), 1559 (2023).","DOI":"10.3390\/biomedicines11061559"},{"issue":"11","key":"97831_CR34","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s00125-018-4713-0","volume":"61","author":"G Hajmousa","year":"2018","unstructured":"Hajmousa, G. et al. Human adipose tissue-derived stromal cells act as functional pericytes in mice and suppress high-glucose-induced proinflammatory activation of bovine retinal endothelial cells. Diabetologia 61(11), 2371\u20132385 (2018).","journal-title":"Diabetologia"},{"issue":"7","key":"97831_CR35","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1161\/ATVBAHA.119.312726","volume":"39","author":"B Icli","year":"2019","unstructured":"Icli, B. et al. MicroRNA-615-5p regulates angiogenesis and tissue repair by targeting AKT\/eNOS (protein kinase B\/endothelial nitric oxide synthase) signaling in endothelial Cells. Arterioscler. Thromb. Vasc Biol. 39(7), 1458\u20131474 (2019).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"97831_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopha.2014.10.020","volume":"70","author":"S Okizaki","year":"2015","unstructured":"Okizaki, S. et al. Suppressed recruitment of alternatively activated macrophages reduces TGF-beta1 and impairs wound healing in streptozotocin-induced diabetic mice. Biomed. Pharmacother. 70, 317\u2013325 (2015).","journal-title":"Biomed. Pharmacother"},{"key":"97831_CR37","doi-asserted-by":"crossref","unstructured":"Feng, J. et al. Oxidative stress and lipid peroxidation: prospective associations between ferroptosis and delayed wound healing in diabetic ulcers. Front. Cell Dev. Biol. 10(8), 898657 (2022).","DOI":"10.3389\/fcell.2022.898657"},{"key":"97831_CR38","doi-asserted-by":"publisher","first-page":"e23407","DOI":"10.1002\/jbt.23407","volume":"37","author":"G Jiang","year":"2023","unstructured":"Jiang, G. et al. Mitochondrial dysfunction and oxidative stress in diabetic wound. J. Biochem. Mol. Toxicol. Vol. 37, e23407 (2023).","journal-title":"J. Biochem. Mol. Toxicol. Vol"},{"issue":"8","key":"97831_CR39","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41565-024-01660-y","volume":"19","author":"T Wei","year":"2024","unstructured":"Wei, T. et al. Janus liposozyme for the modulation of redox and immune homeostasis in infected diabetic wounds. Nat. Nanotechnol. 19(8), 1178\u20131189 (2024).","journal-title":"Nat. Nanotechnol"},{"issue":"12","key":"97831_CR40","first-page":"1866","volume":"58","author":"S Vuj\u010di\u0107","year":"2022","unstructured":"Vuj\u010di\u0107, S. et al. Oxidative stress and inflammatory biomarkers in patients with diabetic foot. Med. (Kaunas). 58(12), 1866 (2022).","journal-title":"Med. (Kaunas)"},{"key":"97831_CR41","doi-asserted-by":"crossref","unstructured":"Qi, X. et al. An immunomodulatory hydrogel by hyperthermia-assisted self-cascade glucose depletion and ROS scavenging for diabetic foot ulcer wound therapeutics. Adv. Mater. 35(48), e2306632. (2023).","DOI":"10.1002\/adma.202306632"},{"issue":"1","key":"97831_CR42","doi-asserted-by":"publisher","first-page":"e1005800","DOI":"10.1371\/journal.pgen.1005800","volume":"12","author":"M Telorack","year":"2016","unstructured":"Telorack, M. et al. A glutathione-Nrf2-thioredoxin cross-talk ensures keratinocyte survival and efficient wound repair. Plos Genet. 12(1), e1005800 (2016).","journal-title":"Plos Genet."},{"issue":"6","key":"97831_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.molmet.2015.04.001","volume":"4","author":"LA Katunga","year":"2015","unstructured":"Katunga, L. A. et al. Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy. Mol. Metab. 4(6), 493\u2013506 (2015).","journal-title":"Mol. Metab."},{"issue":"1","key":"97831_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pathophys.2016.11.002","volume":"24","author":"O Sakai","year":"2017","unstructured":"Sakai, O. et al. Role of GPX4 in human vascular endothelial cells, and the compensatory activity of brown rice on GPX4 ablation condition. Pathophysiology 24(1), 9\u201315 (2017).","journal-title":"Pathophysiology"},{"issue":"3","key":"97831_CR45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.diabres.2011.08.004","volume":"94","author":"AK Arya","year":"2011","unstructured":"Arya, A. K. et al. Relationship between oxidative stress and apoptotic markers in lymphocytes of diabetic patients with chronic non healing wound. Diabetes Res. Clin. Pract. Vol. 94(3), 377\u2013384 (2011).","journal-title":"Diabetes Res. Clin. Pract. Vol"},{"key":"97831_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.biopha.2018.10.070","volume":"109","author":"N Shivavedi","year":"2019","unstructured":"Shivavedi, N. et al. Ascorbic acid therapy: A potential strategy against comorbid depression-like behavior in streptozotocin-nicotinamide-induced diabetic rats. Biomed. Pharmacotherapy = Biomedecine Pharmacotherapie. 109, 351\u2013359 (2019).","journal-title":"Biomed. Pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"06","key":"97831_CR47","first-page":"380","volume":"31","author":"Z Yu","year":"2019","unstructured":"Yu, Z. et al. Effect of dracorhodin perchlorate on angiogenesis of human umbilical vein endothelial cells . Chin. J. Aesthetic Plast. Surg. 31(06), 380\u2013382 (2019).","journal-title":"Chin. J. Aesthetic Plast. Surg."},{"key":"97831_CR48","doi-asserted-by":"publisher","first-page":"115915","DOI":"10.1016\/j.biopha.2023.115915","volume":"169","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Dexmedetomidine alleviates ferroptosis following hepatic ischemia-reperfusion injury by upregulating Nrf2\/GPx4-dependent antioxidant responses. Biomed. Pharmacotherapy = Biomedecine Pharmacotherapie. 169, 115915 (2023).","journal-title":"Biomed. Pharmacotherapy = Biomedecine Pharmacotherapie"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97831-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97831-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97831-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:38:51Z","timestamp":1744371531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97831-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97831"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97831-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12492"}}